Cargando…

De-Intensification Of Blood Glucose Lowering Medication In People Identified As Being Over-Treated: A Mixed Methods Study

AIM: To evaluate if, one year after notification of possible overtreatment, diabetes care providers de-intensified glucose-lowering medications and to gain insight into the opinions and beliefs of both care providers and patients regarding de-intensification. METHODS: Mixed methods using routine car...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hart, Huberta E, Ditzel, Kim, Rutten, Guy E, de Groot, Esther, Seidu, Samuel, Khunti, Kamlesh, Vos, Rimke C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804671/ https://www.ncbi.nlm.nih.gov/pubmed/31695339 http://dx.doi.org/10.2147/PPA.S208947

Ejemplares similares

Internet-based Self-Management Support for Patients With Well-Controlled Type 2 Diabetes: A Real-Life Study
por: Hart, Huberta E, et al.
Publicado: (2017)

A simple to implement and low-cost supervised walking programme in highly motivated individuals with or at risk for type 2 diabetes: An observational study with a pre-post design
por: Hoogendoorn, Sonja W., et al.
Publicado: (2018)

Individualised targets for insulin initiation in type 2 diabetes mellitus—the influence of physician and practice: a cross-sectional study in eight European countries
por: Boels, Anne Meike, et al.
Publicado: (2019)

Inappropriate intensification of glucose-lowering treatment in older patients with type 2 diabetes: the global DISCOVER study
por: Bongaerts, Brenda, et al.
Publicado: (2021)

Type 2 diabetes and COPD: treatment in the right healthcare setting? An observational study
por: Willink, R. P., et al.
Publicado: (2021)

What determines treatment satisfaction of patients with type 2 diabetes on insulin therapy? An observational study in eight European countries
por: Boels, Anne Meike, et al.
Publicado: (2017)

The impact of the new Dutch guideline on cardiovascular risk management in patients with COPD: a retrospective study
por: Nies, Lonneke ME, et al.
Publicado: (2021)

Editorial: Achieving Effective Management and Treatment of Diabetes Mellitus in Future Primary Care
por: Widyahening, Indah Suci, et al.
Publicado: (2022)

Editorial: Achieving Efficient Diabetes Care Through Understanding the Risk Factors, Markers, and Patient Experiences
por: Chew, Boon-How, et al.
Publicado: (2022)

Diabetes-Related Distress and Depressive Symptoms Are Not Merely Negative over a 3-Year Period in Malaysian Adults with Type 2 Diabetes Mellitus Receiving Regular Primary Diabetes Care
por: Chew, Boon-How, et al.
Publicado: (2017)

Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes
por: Paul, Sanjoy K, et al.
Publicado: (2015)

Therapeutic inertia in type 2 diabetes: prevalence, causes, consequences and methods to overcome inertia
por: Khunti, Sachin, et al.
Publicado: (2019)

Effectiveness of shared goal setting and decision making to achieve treatment targets in type 2 diabetes patients: A cluster‐randomized trial (OPTIMAL)
por: Den Ouden, Henk, et al.
Publicado: (2017)

Benefits and harms of sodium‐glucose co‐transporter‐2 inhibitors (SGLT2‐I) and renin–angiotensin–aldosterone system inhibitors (RAAS‐I) versus SGLT2‐Is alone in patients with type 2 diabetes: A systematic review and meta‐analysis of randomized controlled trials
por: Seidu, Samuel, et al.
Publicado: (2021)

Hazardous thunderstorm intensification over Lake Victoria
por: Thiery, Wim, et al.
Publicado: (2016)

Comparison of perceptions of obesity among adults with central obesity with and without additional cardiometabolic risk factors and among those who were formally obese, 3 years after screening for central obesity
por: den Engelsen, Corine, et al.
Publicado: (2015)

Diabetes-Related Distress, Depression and Distress-Depression among Adults with Type 2 Diabetes Mellitus in Malaysia
por: Chew, Boon-How, et al.
Publicado: (2016)

Shared decision making in type 2 diabetes with a support decision tool that takes into account clinical factors, the intensity of treatment and patient preferences: design of a cluster randomised (OPTIMAL) trial
por: den Ouden, Henk, et al.
Publicado: (2015)

Effectiveness of diabetes self-management education via a smartphone application in insulin treated type 2 diabetes patients – design of a randomised controlled trial (‘TRIGGER study’)
por: Boels, Anne Meike, et al.
Publicado: (2018)

Insulin Therapy in Type 2 Diabetes Is Associated With Barriers to Activity and Worse Health Status: A Cross-Sectional Study in Primary Care
por: Boels, Anne Meike, et al.
Publicado: (2021)

Priorities of patients with multimorbidity and of clinicians regarding treatment and health outcomes: a systematic mixed studies review
por: Sathanapally, Harini, et al.
Publicado: (2020)

Effectiveness of diabetes self-management education and support via a smartphone application in insulin-treated patients with type 2 diabetes: results of a randomized controlled trial (TRIGGER study)
por: Boels, Anne Meike, et al.
Publicado: (2019)

Use of Metformin and Cardiovascular Effects of New Classes of Glucose-Lowering Agents: A Meta-analysis of Cardiovascular Outcome Trials in Type 2 Diabetes
por: Zaccardi, Francesco, et al.
Publicado: (2021)

Diabetes care providers’ opinions and working methods after four years of experience with a diabetes patient web portal; a survey among health care providers in general practices and an outpatient clinic
por: Ronda, Maaike C. M., et al.
Publicado: (2018)

Effectiveness of the Beyond Good Intentions Program on Improving Dietary Quality Among People With Type 2 Diabetes Mellitus: A Randomized Controlled Trial
por: van der Velde, Laura A., et al.
Publicado: (2021)

Indirect impact of the COVID-19 pandemic on hospitalisations for cardiometabolic conditions and their management: A systematic review
por: Seidu, Samuel, et al.
Publicado: (2021)

Intensive versus standard blood pressure control in older persons with or without diabetes: a systematic review and meta-analysis of randomised controlled trials
por: Seidu, Samuel, et al.
Publicado: (2023)

Diabetes self-management education after pre-selection of patients: design of a randomised controlled trial
por: Vos, Rimke C., et al.
Publicado: (2016)

Deprescribing in cardiometabolic conditions in older patients: a systematic review
por: Hickman, Elizabeth, et al.
Publicado: (2023)

Cluster randomised trial on the effectiveness of a computerised prompt to refer (back) patients with type 2 diabetes
por: Ronda, Maaike C. M., et al.
Publicado: (2018)

Validity and reliability of a Malay version of the brief illness perception questionnaire for patients with type 2 diabetes mellitus
por: Chew, Boon-How, et al.
Publicado: (2017)

Protocol for an observational cohort study investigating personalised medicine for intensification of treatment in people with type 2 diabetes mellitus: the PERMIT study
por: Bidulka, Patrick, et al.
Publicado: (2021)

Atmospheric rivers fueling the intensification of fog and haze over Indo-Gangetic Plains
por: Verma, Shivali, et al.
Publicado: (2022)

Intensification to injectable therapy in type 2 diabetes: mixed methods study (protocol)
por: de Lusignan, Simon, et al.
Publicado: (2019)

Outcome trends in people with heart failure, type 2 diabetes mellitus and chronic kidney disease in the UK over twenty years
por: Lawson, Claire A, et al.
Publicado: (2021)

Population-based screen-detected type 2 diabetes mellitus is associated with less need for insulin therapy after 10 years
por: Vos, Rimke C, et al.
Publicado: (2020)

Treatment patterns and glycated haemoglobin levels over 36 months in individuals with type 2 diabetes initiating second‐line glucose‐lowering therapy: The global DISCOVER study
por: Charbonnel, Bernard H., et al.
Publicado: (2022)

Process intensification through microbial strain evolution: mixed glucose-xylose fermentation in wheat straw hydrolyzates by three generations of recombinant Saccharomyces cerevisiae
por: Novy, Vera, et al.
Publicado: (2014)

Oral Semaglutide Reduces HbA(1c) and Body Weight in Patients with Type 2 Diabetes Regardless of Background Glucose-Lowering Medication: PIONEER Subgroup Analyses
por: Pratley, Richard E., et al.
Publicado: (2021)

Diabetes patient preferences for glucose-monitoring technologies: results from a discrete choice experiment in Poland and the Netherlands
por: Smith, Ian P, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7v7kp7d5omkmphh1jk5qupsdfb